Mutual Of America Capital Management LLC Clovis Oncology, Inc. Transaction History

Mutual Of America Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$29.37 - $49.48 $1.15 Million - $1.93 Million	-39,081 Closed	0 $0
Q4 2017 Jan 31, 2018	BUY	$57.69 - $84.58 $15,460 - $22,667	268 Added 0.69%	39,081 $2.66 Million
Q3 2017 Oct 18, 2017	BUY	$67.17 - $84.81 $2.61 Million - $3.29 Million	38,813	38,813 $3.2 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.